Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-κb ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism-Reference-Cited by-同舟云学术

Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-κb ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism

Published:2004-07 Issue:1 Volume:35 Page:256-265
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Stilgren L.S,Rettmer E,Eriksen E.F,Hegedüs L,Beck-Nielsen H,Abrahamsen B

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference41 articles.

1. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone;McSheehy;Endocrinology,1986

2. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function;Anderson;Nature,1997

3. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand;Hsu;Proc. Natl. Acad. Sci. U. S. A.,1999

4. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology;Hofbauer;J. Mol. Med.,2001

5. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation;Lacey;Cell,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiency;Endocrine;2023-05-03

2. Denosumab for Osteoporosis in Patients With Primary Hyperparathyroidism and Renal Insufficiency;2022-11-23

3. PTHR1 in Bone;GPCRs as Therapeutic Targets;2022-09-16

4. Bone biomarkers in de novo renal transplant recipients;Clinica Chimica Acta;2020-02

5. Parathyroid Hormones;Hormonal Signaling in Biology and Medicine;2020